Market Overview:
The global narcolepsy market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to factors such as increasing prevalence of narcolepsy, growing awareness about the disorder, and rising demand for effective treatment options. The global narcolepsy market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into daytime extreme sleepiness, cataplexia, and others. The daytime extreme sleepiness segment accounted for the largest share of the global narcolepsy market in 2017 owing to its high prevalence rate. On the basis of application, hospitals accounted for a major share of the global narcolepsy market in 2017 due to increased awareness about diagnosis and treatment options for patients withnarcolepsy among healthcare professionals In terms regional analysis North America held a dominant position in terms revenue contribution followed by Europe during 2017 while Asia Pacific is projected as fastest growing region over forecast period owing rapid industrialization which has led an increase number people suffering from lifestyle diseases including Narcolepsy .
Product Definition:
narcolepsy is a sleep disorder characterized by excessive daytime sleepiness, cataplexy, and hypnagogic hallucinations. Narcolepsy can cause problems with work, school, and social activities.
Daytime Extreme Sleepiness:
Narcolepsy is a chronic sleep disorder characterized by sudden uncontrollable sleep attacks. It affects one out of every five thousand people in the U.S., according to the National Institute of Neurological Disorders and Stroke (NINDS). People with narcolepsy are often described as feeling “ wired ” or energized during the day, but unable to maintain wakefulness at night.
Cataplexia:
Cataplexia is the sudden onset of muscle weakness due to loss of motor control. It may affect any part of body including arms, legs, trunk and face. The attack may last for few minutes or hours but always comes with warning signs that help in its diagnosis such as sleep disturbance (narcolepsy), catarrh, head trauma and infections among others.
Application Insights:
Hospital application segment led the global market in 2017. The segment is expected to witness significant growth over the forecast period owing to rising prevalence of chronic diseases, especially diabetes and depression. According to a study published in NCBI, it was found that around 1 in 5 people aged between 15 and 44 have suffered from depression at some point of time during their life. Moreover, as per WHO, around half of the population of developing countries are suffering from obesity or are susceptible to become obese due largelyto unhealthy eating habits and lack of physical activity among adults. These factors indicate a high potential for new patients suffering from narcolepsy with cataplexy at any given time who can be diagnosed through sleep studies conducted at hospitals or clinics near them.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period due to increasing awareness about narcolepsy and its treatment, availability of drugs such as Provigil (Modafinil) for treating cataplexy, and development of healthcare infrastructure. Moreover, rising prevalence of obesity in this region is also contributing towards growth of the regional market.
Asia Pacific is anticipated to be one of the fastest-growing regions over the forecast period owing to developing economies such as China and India along with other Southeast Asian countries. Increasing disposable income coupled with growing target population base will drive growth further in Asia Pacific region during 2018 - 2030 time frame.
Growth Factors:
- Increasing awareness about narcolepsy and its symptoms will drive the growth of the market.
- Rising incidence of narcolepsy will fuel the demand for drugs and therapies for this disorder.
- Growing research and development activities for new drugs to treat narcolepsy will provide impetus to the market growth.
- increasing number of people with sleep apnea is also expected to increase the prevalence rate of narcolepsy, thereby propelling market growth
Scope Of The Report
Report Attributes
Report Details
Report Title
Narcolepsy Market Research Report
By Type
Daytime Extreme Sleepiness, Cataplexia, Others
By Application
Hospitals, Clinics, Others
By Companies
Jazz Pharmaceuticals, Bioprojet, Arena Pharmaceuticals, Graymark Healthcare, Mylan, Teva Pharmaceutical Industries, Novartis, Takeda, Shionogi, Ligand Pharmaceuticals
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
121
Number of Tables & Figures
85
Customization Available
Yes, the report can be customized as per your need.
Global Narcolepsy Market Report Segments:
The global Narcolepsy market is segmented on the basis of:
Types
Daytime Extreme Sleepiness, Cataplexia, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Jazz Pharmaceuticals
- Bioprojet
- Arena Pharmaceuticals
- Graymark Healthcare
- Mylan
- Teva Pharmaceutical Industries
- Novartis
- Takeda
- Shionogi
- Ligand Pharmaceuticals
Highlights of The Narcolepsy Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Daytime Extreme Sleepiness
- Cataplexia
- Others
- By Application:
- Hospitals
- Clinics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Narcolepsy Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Narcolepsy is a sleep disorder that causes people to have sudden episodes of sleepiness, usually during the daytime. These episodes can last from a few minutes to several hours. Narcolepsy may also cause hallucinations and extreme daytime drowsiness.
Some of the key players operating in the narcolepsy market are Jazz Pharmaceuticals, Bioprojet, Arena Pharmaceuticals, Graymark Healthcare, Mylan, Teva Pharmaceutical Industries, Novartis, Takeda, Shionogi, Ligand Pharmaceuticals.
The narcolepsy market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Narcolepsy Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Narcolepsy Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Narcolepsy Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Narcolepsy Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Narcolepsy Market Size & Forecast, 2018-2028 4.5.1 Narcolepsy Market Size and Y-o-Y Growth 4.5.2 Narcolepsy Market Absolute $ Opportunity
Chapter 5 Global Narcolepsy Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Narcolepsy Market Size Forecast by Type
5.2.1 Daytime Extreme Sleepiness
5.2.2 Cataplexia
5.2.3 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Narcolepsy Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Narcolepsy Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Narcolepsy Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Narcolepsy Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Narcolepsy Analysis and Forecast
9.1 Introduction
9.2 North America Narcolepsy Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Narcolepsy Market Size Forecast by Type
9.6.1 Daytime Extreme Sleepiness
9.6.2 Cataplexia
9.6.3 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Narcolepsy Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Narcolepsy Analysis and Forecast
10.1 Introduction
10.2 Europe Narcolepsy Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Narcolepsy Market Size Forecast by Type
10.6.1 Daytime Extreme Sleepiness
10.6.2 Cataplexia
10.6.3 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Narcolepsy Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Narcolepsy Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Narcolepsy Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Narcolepsy Market Size Forecast by Type
11.6.1 Daytime Extreme Sleepiness
11.6.2 Cataplexia
11.6.3 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Narcolepsy Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Narcolepsy Analysis and Forecast
12.1 Introduction
12.2 Latin America Narcolepsy Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Narcolepsy Market Size Forecast by Type
12.6.1 Daytime Extreme Sleepiness
12.6.2 Cataplexia
12.6.3 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Narcolepsy Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Narcolepsy Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Narcolepsy Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Narcolepsy Market Size Forecast by Type
13.6.1 Daytime Extreme Sleepiness
13.6.2 Cataplexia
13.6.3 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Narcolepsy Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Narcolepsy Market: Competitive Dashboard
14.2 Global Narcolepsy Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Jazz Pharmaceuticals
14.3.2 Bioprojet
14.3.3 Arena Pharmaceuticals
14.3.4 Graymark Healthcare
14.3.5 Mylan
14.3.6 Teva Pharmaceutical Industries
14.3.7 Novartis
14.3.8 Takeda
14.3.9 Shionogi
14.3.10 Ligand Pharmaceuticals